C
RVMD icon

Covestor’s Revolution Medicines RVMD Stock Holding History

Covestor’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$176K Sell
936
-1,904
-67% -$278K 0.1% 160
2026
Q1 		$276K Buy
2,840
+2,581
+997% +$261K 0.19% 79
2025
Q4 		$21K Buy
259
+13
+5% +$852 0.01% 1273
2025
Q3 		$11K Buy
246
+3
+1% +$117 0.01% 1566
2025
Q2 		$9K Hold
243
– – 0.01% 1649
2025
Q1 		$9K Buy
243
+1
+0.4% +$41 0.01% 1579
2024
Q4 		$11K Sell
242
-6
-2% -$303 0.01% 1500
2024
Q3 		$11K Sell
248
-107
-30% -$4.66K 0.01% 1514
2024
Q2 		$14K Buy
355
+2
+0.6% +$75 0.01% 1350
2024
Q1 		$11K Buy
353
+30
+9% +$889 0.01% 1533
2023
Q4 		$9K Buy
323
+317
+5,283% +$7.62K 0.01% 1655
2023
Q3 		$0 Hold
6
– – ﹤0.01% 2618
2023
Q2 		$0 Sell
6
-1
-14% -$25 ﹤0.01% 2569
2023
Q1 		$0 Sell
7
-1
-13% -$25 ﹤0.01% 2494
2022
Q4 		$0 Sell
8
-1
-11% -$21 ﹤0.01% 2516
2022
Q3 		$0 Sell
9
-1
-10% -$22 ﹤0.01% 2498
2022
Q2 		$0 Sell
10
-3
-23% -$58 ﹤0.01% 2295
2022
Q1 		$0 Sell
13
-4
-24% -$87 ﹤0.01% 2396
2021
Q4 		$0 Buy
+17
New +$479 ﹤0.01% 2279

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Covestor's RVMD Position: Q2 2026 in Review

Covestor reduced its Revolution Medicines (RVMD) stake by 67% in Q2 2026, selling an estimated $278K and leaving 936 shares worth $176K. The position accounts for 0.1% of the portfolio, ranked #160.

Covestor first reported a position in RVMD in Q4 2021 and has held it in 19 quarters since. The position peaked at $276K in Q1 2026. 692 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Covestor held 936 shares of Revolution Medicines worth $176K as of Q2 2026.
  • Covestor sold 1,904 Revolution Medicines shares in Q2 2026, an estimated $278K.
  • Revolution Medicines made up 0.1% of Covestor's portfolio in Q2 2026, its #160 holding.
  • Covestor first reported a position in Revolution Medicines in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Revolution Medicines position peaked at $276K in Q1 2026.
  • 692 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.